Hot Healthcare Equipment Companies To Invest In Right Now

Last year I made 10 predictions for 2013. Some were bolder than others. As always, I promised to review these at the end of the year and give myself a score card. The first five predictions made on December 11, 2012 were:

1. U.S. GDP growth would remain tepid in the first half of the year, before picking up to a near 3% rate during the second half.

2. Stocks will be very volatile in January and through the first quarter, but thereafter should regain their upward momentum to allow the S&P to gain about 6% in 2013.

3. Average gasoline prices in the U.S. will rise above $4.50 by Memorial Day.

4. Europe will remain in recession for most of the year, ultimately forcing a Greek exit from the currency zone.

5. Housing drops again, after banks release a large chunk of their foreclosure inventory onto the market. This should be temporary.

Top 10 Mid Cap Stocks To Buy Right Now: Madison Square Garden Inc.(MSG)

The Madison Square Garden Company, together with its subsidiaries, operates in the sports, entertainment, and media businesses primarily in the United States. The company operates in three segments: MSG Media, MSG Entertainment, and MSG Sports. The MSG Media segment produces and develops content for various distribution platforms, including content originating from the company?s venues. It consists of the MSG Networks and the Fuse Networks, which offer sports and musical content. This segment also manages interactive businesses that comprise a range of targeted websites; and wireless, video on demand, and digital platforms. The MSG Entertainment segment creates, produces, and/or presents various live productions, as well as presents or hosts other live entertainment events, such as concerts, family shows, special events, and theatrical productions. The MSG Sports segment owns and operates sports franchises. This segment also owns other sports properties, including the pre sentation of a range of live sporting events, such as professional boxing, college basketball, track and field, and tennis. The company owns the Madison Square Garden complex in New York City, which includes an arena and a theater; and The Chicago Theatre in Chicago. It leases Radio City Music Hall and the Beacon Theatre in New York City. The company is based in New York, New York. As of February 09, 2010, Madison Square Garden, Inc. operates independently of Cablevision Systems Corporation.

Advisors' Opinion:

• [By Jayson Derrick]

  Analysts at ISI Group downgraded The Madison Square Garden Company (NYSE: MSG) to Neutral from Buy. Shares hit new 52-week highs of $65.57 before closing the day at $65.08.

Hot Healthcare Equipment Companies To Invest In Right Now: Powershares S & P Small Cap Energy Portfolio (PSCE)

PowerShares S&P SmallCap Energy Portfolio (the Fund) seeks investment results that correspond generally to the price and yield performance of an index called the S&P SmallCap 600 Capped Energy Index (the Underlying Index). The Underlying Index consists of common stocks of the United States energy companies that are principally engaged in the business of producing, distributing or servicing energy-related products, including oil and gas exploration and production, refining, oil services, pipeline, and solar, wind and other non-oil-based energy. The Underlying Index is compiled, maintained and calculated by Standard & Poor's Financial Services LLC (Standard & Poor's). The Fund will normally invest at least 80% of its total assets in common stocks of small-capitalization energy companies. The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Underlying Index. The Fund�� investment adviser is Invesco PowerShares Capital Management LLC. Advisors' Opinion:

• [By John Udovich]

  Yesterday, small cap oil and gas stock Penn Virginia Corporation (NYSE: PVA) surged 14.84% after reporting earnings and was also rising close to 6% in�pre-market trading���meaning it might be worth taking a closer look at the small cap along with the performance of ETF peers IQ Global Oil Small Cap ETF (NYSEARCA: IOIL) and PowerShares S&P SmallCap Energy Portfolio (NASDAQ: PSCE). After all, a look at the longer term chart of Penn Virginia Corporation does not reveal a pretty picture for investors over the long haul.

Hot Healthcare Equipment Companies To Invest In Right Now: Hexcel Corp (HXL)

Hexcel Corporation (Hexcel), incorporated in 1948, is a composites company. The Company develops, manufactures and markets composites, including carbon fibers, reinforcements, prepregs, honeycomb, matrix systems, adhesives and composite structures, for use in Commercial Aerospace, Space and Defense, and Industrial Applications. Its products are used in a variety of end applications, such as commercial and military aircraft, space launch vehicles and satellites, wind turbine blades, automotive, bikes, skis and a variety of other industrial applications. Hexcel has two segments: Composite Materials and Engineered Products. The Composite Materials consists of carbon fiber, reinforcements for composites, honeycomb core and matrix product lines. The Engineered Products consists of composite structures and specially machined honeycomb product lines.

Composite Materials

The Composite Materials segment manufactures and markets carbon fibers, fabrics and specialty reinforcements, prepregs, structural adhesives, honeycomb, composite panels, molding compounds, polyurethane systems and laminates that are incorporated into many applications, including military and commercial aircraft, wind turbine blades, recreational products and other industrial applications. HexTow carbon fibers are manufactured for sale to third-party customers, as well as for its own use in manufacturing certain reinforcements and composite materials. Carbon fibers are woven into carbon fabrics, used as reinforcement in conjunction with a resin matrix to produce pre-impregnated composite materials. Carbon fibers is also used in filament winding, hand layup, automatic tape layup and advanced fiber placement to produce finished composite components. Its carbon fibers��product applications include structural components for commercial and military aircraft, space launch vehicles, and certain other applications, such as recreational and industrial equipment.

Industrial fabrics and specialty reinforcements are ma! de from a variety of fibers, including carbon, aramid and other polymers, several types of fiberglass, quartz, ceramic and other specialty fibers. These reinforcements are used in the production of prepregs and other matrix materials used in primary and secondary structural aerospace applications, such as wing components, horizontal and vertical stabilizer components, fairings, radomes and engine nacelles, as well as overhead storage bins and other interior components. Hexcel�� reinforcements are also used in the manufacture of a variety of industrial and recreational products, such as wind energy blades, automotive components, boats, surfboards, skis and other sporting goods equipment.

HexPly prepregs are manufactured for sale to third-party customers and for internal use by its engineered products segment in manufacturing composite laminates and monolithic structures, including finished components for aircraft structures and interiors. Prepregs are manufactured by combining reinforcement fabrics or unidirectional fibers with a resin matrix to form a composite material with structural properties not present in either of the constituent materials. Reinforcement fabrics used in the manufacture of prepregs include glass, carbon, aramid, quartz, ceramic and other specialty reinforcements. Resin matrices include bismaleimide, cyanate ester, epoxy, phenolic, polyester, polyimide and other specialty resins.

Other fiber reinforced matrix developments include HexMC, a form of quasi-isotropic carbon fiber prepreg that enables small to medium sized composite components to be mass produced. HexTOOL is a specialized form of HexMC for use in the construction of high temperature composite tooling. HexFIT film infusion material is a product that combines resin films and dry fiber reinforcements in production and enables the manufacture of contoured composite structures, such as wind turbine blades.

Polymer matrix materials are sold in bulk and film form for use in direct pro! cess manu! facturing of composite parts. Resins can be combined with fiber reinforcements in manufacturing processes, such as resin transfer molding (RTM), resin film infusion (RFI) or vacuum assisted resin transfer molding (VARTM) to produce composite components for both aerospace and industrial applications. Hexcel manufactures and markets a range of Redux film and paste adhesives. These structural adhesives, which bond metal to metal and composites and honeycomb structures, are used in the aerospace industry and for many industrial applications.

HexWeb honeycomb is a cellular structure consisting of nested hexagonal cells. The product is similar in appearance to a cross-sectional slice of a beehive. It can also be manufactured in asymmetric cell configurations for more specialized applications. Honeycomb is primarily used as a lightweight core material and acts as an energy absorber. When sandwiched between composite or metallic facing skins, honeycomb increases the stiffness of the structure, while adding very little weight. The Company produces honeycomb from a number of metallic and non-metallic materials. Its metallic honeycomb is made from aluminum and is available in a selection of alloys, cell sizes and dimensions. Non-metallic materials used in the manufacture of honeycomb include fiberglass, carbon fiber, thermoplastics, non-flammable aramid papers, aramid fiber and other specialty materials. During the year ended December 31, 2011, revenues for the Composite Materials segment to third-party customers represented approximately 77% of its total revenues.

Engineered Products

The Engineered Products segment manufactures and markets composite structures and precision machined honeycomb parts for use in the aerospace industry. Composite structures are manufactured from a variety of composite and other materials, including prepregs, honeycomb, structural adhesives and advanced molding materials, using such manufacturing processes, as autoclave processing, multi-axis nu! merically! controlled machining, heat forming, compression molding and other composite manufacturing techniques. During 2011, revenues for the Engineered Products segment to third-party customers represented approximately 23% of its total revenues. The Engineered Products business unit has a 50% ownership interest in a Malaysian joint venture, Asian Composites Manufacturing Sdn. Bhd.

Advisors' Opinion:

• [By Seth Jayson]

  Hexcel (NYSE: HXL  ) reported earnings on July 22. Here are the numbers you need to know.

  The 10-second takeaway
  For the quarter ended June 30 (Q2), Hexcel met expectations on revenues and beat expectations on earnings per share.

• [By Rich Smith]

  This series, brought to you by Yahoo! Finance, looks at which upgrades and downgrades make sense, and which ones investors should act on. Today, our headlines include a pair of aerospace upgrades for European Aeronautic Defence and Space Company (NASDAQOTH: EADSY  ) and Hexcel (NYSE: HXL  ) . But it's not all good news, so let's start off by finding out why.

• [By John Persinos]

  The standout stocks in this segment are Hexcel Corp. (HXL), the leading producer of carbon composites, and Allegheny Technologies (ATI), which dominates the market in titanium.

Hot Healthcare Equipment Companies To Invest In Right Now: Powerdyne International Inc (PWDY)

Powerdyne International, Inc., formerly Greenmark Acquisition Corporation, incorporated on September 13, 2006, is a development-stage company. The Company focuses on manufacturing, installing, maintaining, owning and operating portable electrical power generation equipment (gensets).

The Company's initial product is the PDIGenset, which is a self contained generator that is powered by a modified radial air cooled engine to drive a minimum of a 1-megawatt generator. The entire unit, which runs on natural gas or propane, is compact, lightweight and clean burning. The Company also focuses on the process of building its first prototype of the PDIGenset. As of December 31, 2010, the Company had not generated any revenues.

The Company competes with Caterpillar Corporation, Cummings, Morse Diesel, Kohler, Volvo and Detroit Diesel.

Advisors' Opinion:

• [By Peter Graham]

  On Friday, small cap stocks EHouse Global (OTCBB: EHOS), Sanwire Corporation (OTCMKTS: SNWR) and Powerdyne International Inc (OTCBB: PWDY) sank 37.38%, 29.47% and 23.23%, respectively, despite some evidence of paid stock promotions or investor relation campaigns. Of course, volatility is a given for small cap OTC stocks, but paid stock promotions or investor relations campaigns tend to add to that volatility. With that in mind, what will these three small cap stocks do for investors this holiday trading week? Here is a closer look to help you decide on a trading or investment strategy:

Hot Healthcare Equipment Companies To Invest In Right Now: Danske Bank A/S (DANSKE)

Danske Bank A/S (the Bank) is a Denmark-based bank. Its operations are divided into five business segments: Banking Activities caters to personal and business customers, comprising finance centers, mortgage finance operations and real estate agency operations, as well as property finance operations; Danske Markets and Treasury is responsible for the Bank�� activities in the financial markets, such as trading in fixed income, foreign exchange, equities and interest-bearing securities, as well as equity portfolios, among others; Danske Capital is engaged in the development and marketing of wealth management products and services; Danica Pension encompasses the Bank�� activities in the life insurance and pensions market; Other Activities encompasses the Bank�� real estate activities and support functions, as well as the elimination of returns on own shares and bonds. Is operational in 15 countries, with emphasis on the Nordic region. Advisors' Opinion:

• [By Namitha Jagadeesh]

  Kabel Deutschland Holding AG rose to a record after getting an offer from Liberty Global Plc. Aveva Group Plc (AVV) jumped 5.4 percent as Citigroup Inc. upgraded the shares. Danske Bank A/S (DANSKE) dropped 6.1 percent after Denmark�� financial regulator ordered it to increase its risk-weighted assets. Royal Imtech NV fell to the lowest price since 2004 after posting a first-quarter loss on costs relating to a fraud investigation.

Hot Healthcare Equipment Companies To Invest In Right Now: Mylan Inc (MYL)

Mylan Inc. (Mylan), incorporated in 1970, is a pharmaceutical company, which develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals. The Company operates a specialty business, which is focused on respiratory, allergy and psychiatric therapies. Through Mylan Laboratories Limited, an Indian subsidiary, it manufactures and supply active pharmaceutical ingredient (API) for its own products and pipeline, as well as for third parties. On December 23, 2011, Mylan completed the acquisition of rights to develop, manufacture and commercialize a generic equivalent to GlaxoSmithKline�� Advair Diskus and Seretide Diskus incorporating Pfizer Inc.��, (Pfizer) dry powder inhaler delivery platform (the Respiratory Delivery Platform). In February 2012, Valeant Pharmaceuticals International, Inc. announced that it has completed the divestiture of 1% clindamycin and 5% benzoyl peroxide gel (IDP-111), a generic version of Benzaclin, and 5% fluorouracil cream, (5-FU), an authorized generic of Efudex, to the Company.

As of December 31, 2011, Mylan marketed a global portfolio of approximately 1,100 different products covering a range of therapeutic categories. It offers a range of dosage forms and delivery systems, including oral solids, topicals, liquids and semi-solids. In addition, it focuses on transdermal patches, high potency formulations, injectables, controlled release and respiratory delivery products. Mylan operates in two segments: Generics and Specialty. Its revenues are derived from the sale of generic and branded generic pharmaceuticals, specialty pharmaceuticals and API. Its generic pharmaceutical business is conducted in the United States and Canada (collectively, North America); Europe, the Middle East, and Africa (collectively, EMEA), and India, Australia, Japan and New Zealand (collectively, Asia Pacific). Its API business is conducted through Mylan Laboratories Limited, which is included within the Asia Pacific region in its Generi! cs segment. Its specialty pharmaceutical business is conducted by Dey Pharma, L.P. (Dey).

Generics Segment

The Company sales in the United States are derived through its wholly owned subsidiary Mylan Pharmaceuticals Inc. (MPI), its primary United States pharmaceutical research, development, manufacturing, marketing and distribution subsidiary, as well as through Mylan Institutional (MI). MPI�� net revenues are derived from the sale of solid oral dosage and transdermal patch products. MI�� net revenues are derived from the sale of its unit dose and injectable product offerings. In the United States, it has product portfolios consisting of approximately 340 products, of which approximately 305 are in capsule or tablet form in an aggregate of approximately 740 dosage strengths. Included in these totals are approximately 40 extended release products in a total of approximately 105 dosage strengths. Also included in it�� the United States product portfolio are four transdermal patch products in a total of 18 dosage strengths, which are developed and manufactured by Mylan Technologies, Inc. (MTI), its wholly owned transdermal technology subsidiary, and marketed and distributed by MPI.

The Company�� North America revenues also include those generated by its wholly owned subsidiary Mylan Pharmaceuticals ULC (MPC), which markets generic pharmaceuticals in Canada. MPC offers a portfolio of approximately 115 products in an aggregate of approximately 250 dosage strengths. Its generic pharmaceutical sales in EMEA are generated by its wholly owned subsidiaries in Europe, through which it has operations in 21 countries.

In France, through the Company�� subsidiary Mylan S.A.S., it markets a retail portfolio of approximately 215 products in an aggregate of approximately 455 dosage strengths. In Italy, it markets through its subsidiary Mylan S.p.A. a portfolio of approximately 150 products in an aggregate of approximately 285 dosage strengths. In Italy, it h! as market! share, based on value and volume, in the company-branded generic retail prescription market. In Spain, it markets through its subsidiary Mylan Pharmaceuticals S.L. a portfolio of approximately 100 products in an aggregate of approximately 220 dosage strengths. In Germany, it markets through its subsidiary Mylan dura a portfolio of approximately 150 products in an aggregate of approximately 330 dosage strengths. In the United Kingdom, it offers a product portfolio of approximately 175 products in an aggregate of approximately 315 dosage strengths. It markets generic pharmaceuticals in Asia Pacific through subsidiaries in Australia, New Zealand, India, Japan and Taiwan.

In Australia, the Company offers a portfolio of approximately 170 products in an aggregate of approximately 440 dosage strengths. Mylan Seiyaku, its wholly owned Japanese subsidiary, offers a portfolio of more than 380 products in an aggregate of approximately 500 dosage strengths. At Mylan Laboratories Limited, its dosage business produces antiretroviral (ARV) products, which are sold outside of India, and other finished dosage form (FDF) products, which are sold to third parties by other Mylan operations globally. In addition, Mylan Laboratories Limited offers a line of FDF products in the ARV market and manufactures non-ARV FDF products that are marketed by Mylan.

Specialty Segment

The Company�� specialty pharmaceutical business is conducted through Dey. Dey�� portfolio consists of branded specialty injectable, nebulized and transdermal products for life-threatening conditions. Dey�� revenues are derived through the sale of the EpiPen Auto-Injector. The EpiPen Auto-Injector, which is used in the treatment of severe allergic reactions, is an epinephrine auto-injector that has been sold in the United States and internationally.

Advisors' Opinion:

• [By George Budwell]

  That being said, Mylan (NASDAQ: MYL  ) , Momenta Pharmaceuticals, and Dr. Reddy's Laboratories have all reportedly been looking into challenging the patent covering this double-dose formulation. And because of the uncertainty surrounding Copaxone's exclusivity, Teva issued a fairly wide guidance for 2014 in the second quarter, ranging from $4.50 to $5.10 for the full year.

• [By Ben Levisohn]

  Mylan (MYL) has dropped 0.9% to $47.50 after the generic-drug maker missed analyst earnings forecasts and lowered the top end of its revenue and profit guidance.